Clinical trial
An Open Label, Descriptive Study to Evaluate the Clinical Utility of a Novel Formulation of Furosemide Delivered Subcutaneously in Patients Presenting With Early Signs of Fluid Overload
NCT03359161 is registered in ClinicalTrials.gov with Steward St. Elizabeth's Medical Center of Boston, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label, Descriptive Study to Evaluate the Clinical Utility of a Novel Formulation of Furosemide Delivered Subcutaneously in Patients Presenting With Early Signs of Fluid Overload
- Lead sponsor
- Steward St. Elizabeth's Medical Center of Boston, Inc.
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- April 5, 2018
- Completion date
- January 31, 2019
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.